Phase 4 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 50 years or older and under 90 years old
- People who have been diagnosed before surgery with a type of bladder cancer that has not grown into the muscle wall (known as non-muscle-invasive bladder cancer, stages Ta to T1)
- People who are scheduled to have a procedure to remove a bladder tumour through the urethra (a minimally invasive surgical procedure)
- People who agree to take part and sign a written consent form
Who may not be able to join:
- People who do not wish to participate
- People who need emergency surgery
- People who also have another type of cancer at the same time
- People who have used a class of sedative or anxiety medications called benzodiazepines within the week before surgery, if that use occurred in the last month before the operation
- People who have a history of schizophrenia, epilepsy, Parkinson's disease, or a muscle weakness condition called myasthenia gravis
- People who are unable to communicate before surgery due to being in a coma, having severe dementia, a language barrier, or being in the final stages of a serious illness
- People who are critically ill, have severe liver disease, or have severe kidney disease requiring dialysis before surgery (confirm with trial site for exact definitions)
- People whose surgery is intended only to help make a diagnosis, or where the surgical team has determined before the operation that the tumour cannot be fully removed
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wang Dong-Xin, MD, PhD, Peking University First Hospital
Phone: 86 10 83572784
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of emergence delirium (early).; Recurrence-free survival (long-term).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.